ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

The activation of CB1 and CB2 inhibits the development of intracellular cAMP, therefore leading to a tremendous reduction in the excitatory outcome within the neurons [88,89]. In addition, the activation of CB2 can more reduce the mast cell degranulation and the discharge of professional-inflammatory mediators, making the reduction in pain feeling